Document |
Document Title |
WO/2017/019875A1 |
Chemical agents, such as disulfonamide derivatives of fluorene, anthracene, xanthene, dibenzosuberone and acridine, and similar heterocyclic ring structures; including, salts thereof that act as anti-cancer and anti-tumor agents, along w...
|
WO/2017/012952A1 |
The invention relates to a method for the catalytic hydroxylation of a phenolic substrate, by hydrogen peroxide, into at least one dihydroxylated product, especially phenol into hydroquinone (HQ) and pyrocatechol (PC), characterised in t...
|
WO/2017/014620A1 |
The invention relates to a food supplement and to a method for improving the meat production efficiency in a bovine animal by means of ethyl ferulate. For the administration of the food supplement to the bovine, the ferulate is pre-mixed...
|
WO/2017/005907A1 |
The invention relates to zeolitic adsorbents based on agglomerated crystals of zeolite X comprising barium, potassium and sodium. These adsorbents are applicable in the separation of fractions of aromatic C8 isomers, especially xylenes.
|
WO/2017/005908A1 |
The invention relates to zeolitic adsorbents based on agglomerated crystals of zeolite X comprising barium, potassium and sodium. These adsorbents are applicable in the separation of fractions of aromatic C8 isomers, especially xylenes.
|
WO/2012/025587A9 |
The present invention is directed to a process for the manufacture of 2,3,5-trimethyl-hydro-p-benzoquinone comprising the following steps: a) hydrogenating 2,6-dimethyl-p-benzoquinone with hydrogen in the presence of a hydrogenation cata...
|
WO/2017/003209A1 |
The present application relates to a distillation apparatus. According to the distillation apparatus of the present application, since a second compound, which has a relatively high boiling point between first and second compounds capabl...
|
WO/2017/003247A1 |
The present application relates to a distillation apparatus. According to the distillation apparatus of the present application, since a methanol removal distillation column is positioned at a location allowing the separation of methanol...
|
WO/2016/205923A1 |
There is disclosed a process for forming an ingestible therapeutic plant source pill. In an embodiment, the process comprises: decarboxylating the plant source material to release carbon dioxide; testing potency of the plant source mater...
|
WO/2016/201188A1 |
The present invention provides mito-honokiol compounds, pharmaceutical compositions thereof, and methods of using the mito-honokiol compounds in the treatment of cancer.
|
WO/2016/196428A1 |
Various processes for the separation of a mixture containing dichlorophenols are described. In various aspects, the present invention relates to separation processes that produce an extract enriched in 2,4-dichlorophenol content and an e...
|
WO/2016/196950A1 |
Compositions for and methods of improving wound healing are disclosed, including compositions for and methods of treating chronic wounds, and compositions for the inhibition and treatment of necrosis and extended quiescence that result i...
|
WO/2016/190024A1 |
This method for producing a hydroxy-substituted aromatic compound involves a step of drying a hydroxy-substituted aromatic compound in an atmosphere in which the oxygen concentration is less than 20 vol%. This method for packaging a hydr...
|
WO/2016/187722A1 |
Ocular compositions comprising a CB2 target agent and a cannabimimetic agent that is a non-selective cannabinoid receptor agent are useful in the treatment of ocular inflammation and ocular neuropathic pain. The CB2 target agent may be a...
|
WO/2016/187678A1 |
In general the present invention concerns a method for conversion of particular 4-alkyl-2- hydroxyphenols and 4-alkyl-2-alkoxyphenols into 3-alkylphenols. More specifically, this invention relates to a novel process of selectively formin...
|
WO/2016/190871A1 |
The present disclosure provides phenolic compounds useful in the treatment of neurological conditions such as convulsions and tremors, having the structure of Formula (I): wherein R2, R4, R5, & R6, are as defined in the detailed descript...
|
WO/2016/188490A1 |
The present invention relates to a method for preparing a compound of general formula (A) and an optical isomer thereof. The preparation method comprises coupling a halogenated phenol derivative with a boron compound and then subjecting ...
|
WO/2016/190044A1 |
A first method for producing a hydroxy-substituted aromatic compound according to the invention involves a step (contact step) of bringing a hydroxy-substituted aromatic compound into contact with an organic solvent and/or water in an at...
|
WO/2016/185865A1 |
The purpose of the present invention is to provide: a novolac-type phenolic-hydroxy-group-containing resin having excellent developability, heat resistance and followability to substrates; and a resist film. A novolac-type phenolic-hydro...
|
WO/2016/181800A1 |
An oxidation reactor with which hydrocarbons can be oxidized efficiently in terms of both reaction efficiency and energy efficiency is provided. This oxidation reactor is equipped with: a liquid introduction channel through which a liqui...
|
WO/2016/020879A9 |
A method of producing phenol and acetone can comprise: alkylating benzene with a C2-6 alkyl source in the presence of a zeolite catalyst to produce a C8-12 alkylbenzene; oxidizing the C8-12 alkylbenzene in the presence of an oxygen conta...
|
WO/2016/176771A1 |
The present description relates to an anti-aging composition comprising at least one plant extract. The composition can comprise at least two different anti-aging agents, wherein one the anti-aging agent is a plant extract. The combinati...
|
WO/2016/171231A1 |
The present invention provides a method for efficiently producing bisphenols at low cost with high conversion rate and high selectivity. The present invention also provides a novel catalyst which is reusable and is suitable for this prod...
|
WO/2016/158457A1 |
The present invention provides a compound represented by formula (1). (In formula (1), R1 represents a C1-30 2n-valent group, and R2-R5 each independently represent a C1-10 straight chain, branched, or cyclic alkyl group, a C6-10 aryl gr...
|
WO/2016/160090A1 |
The present invention, in one or more embodiments, comprises derivatives of 3-n-pentadecylcatechol (poison ivy urushiol saturated congener) and/or 3 -n-heptadecyl catechol (poison oak urushiol saturated congener) as compositions for the ...
|
WO/2016/160647A1 |
The present subject matter relates generally to methods for treating an organic feed. More specifically, the present subject matter relates to methods for reducing the water content of an organic feed before the organic feed enters a hyd...
|
WO/2016/151447A1 |
Disclosed are solid forms of menaquinol and processes for obtaining them by chemical or enzymatic reduction of menaquinone. Said solid forms possess high stability to oxidation which allows effective use of menaquinol in the most common ...
|
WO/2016/153347A1 |
The present invention relates to a process for preparing cannabidiol isolates from industrial hemp. With the process an economically feasible manner is provided of putting industrial hemp waste material to use as a starting material for ...
|
WO/2016/145479A1 |
The present invention relates to novel compounds and their use in the prophylactic and/or therapeutic treatment of fibrosis and fibrosis-related conditions.
|
WO/2016/142568A1 |
The present invention relates to a ferruginol analogue of formula (I) in which R1, R2, R3, and X mean the following, independently: R1 is CH2-phthalimide, CH2-succinimide, CH2-maleimide, CH2-NHCOCH3, CH2-NHCOCF3, CHO, CH2OH, (C1-C6)carbo...
|
WO/2016/144042A1 |
The present invention relates to: 2-methoxy-4-(3-(4-methoxyphenyl)prop-1-en-1-yl)phenol having a novel structure and capable of being used for preventing or treating all diseases associated with NF-κB, IKK and STAT3; and a preparation m...
|
WO/2016/143635A1 |
This compound is represented by formula (1). (In formula (1), R1's are each independently a divalent group having 1-30 carbon atoms, R2 to R7 are each independently a linear, branched, or cyclic alkyl group having 1-10 carbon atoms, an a...
|
WO/2016/139161A1 |
The present invention relates to a new process for preparing 3-chloro-2-vinylphenylsulfonate derivatives.
|
WO/2016/137445A1 |
The present invention provides monomers, analogs, and/or derivatives of bisphenols substituted with one or more fluoromethyl groups. These monomers, analogs, and/or derivatives can be used to form oligomers and/or polymers, which in turn...
|
WO/2016/132975A1 |
The present invention pertains to a novel phosphorous acid ester compound represented by formula (I) [in the formula, R1, R2, R3 and R4 each independently represent a hydrogen atom, an alkyl group having 1-8 carbon atoms, a cycloalkyl gr...
|
WO/2016/127111A1 |
A purified cannabidiol (CBD) extract and/or cannabidiolic acid (CBDA) extract is isolated from industrial hemp and comprises less than 0.5 wt % organic impurities as measured by HPLC and 1H NMR spectroscopy exhibits no detectable peak at...
|
WO/2016/119757A1 |
The present invention relates to a method for preparing a 2-[1-cycloalkylethyl] phenol derivative, i.e. a method for preparing a compound as shown in formula (I) and an isomer thereof, and an intermediate, and the method has the advantag...
|
WO/2016/120925A1 |
Provided is an epoxy resin curing accelerator which exhibits excellent fluidity when filled into a mold, while having high catalytic activity and excellent curability. The present invention is an epoxy resin curing accelerator (Q) which ...
|
WO/2016/119758A1 |
The present invention relates to a method for preparing a chiral 2-[1-cycloalkylethyl] phenol derivative, the preparation method comprises the catalytic hydrogenation of a compound of general formula (II) to prepare and obtain a compound...
|
WO/2016/117295A1 |
The present invention addresses the issue of providing a novel production method for a more thermodynamically stable inclusion compound having, as the host compound therefor, at least one type selected from the group consisting of 1, 1, ...
|
WO/2016/112874A1 |
Disclosed are uses of 3,3',5,5'-tetraisopropyl-4,4'-diphenol, pharmaceutical salts thereof, esterification products thereof, or solvates thereof in the preparation of medicines for the prevention and treatment of cerebral ischemia.
|
WO/2016/114000A1 |
Provided are: a curable composition which is particularly suitable for obtaining permanent resist films, exhibits excellent solubility in a solvent, and is capable of obtaining coating films exhibiting excellent alkaline development prop...
|
WO/2016/112875A2 |
The present invention relates to a diphenyl derivative and uses thereof, the diphenyl derivative having the structure as indicated in formula (I) defined in the description. The uses refer to the uses of the diphenyl derivative, pharmace...
|
WO/2016/114668A1 |
The present invention is directed to a method for preparing a final phenolic product from biomass comprising the steps of providing a furanic compound obtainable from biomass; reacting the furanic compound with a dienophile to obtain a p...
|
WO/2016/114001A1 |
Provided is a phenolic hydroxyl group-containing compound which exhibits excellent solvent solubility, and which is capable of obtaining a composition with which a coating film exhibiting excellent thermal decomposition resistance, alkal...
|
WO/2016/102472A1 |
The present invention relates to the cosmetic use, in a composition containing a physiologically acceptable medium, of at least one compound of formula (1): in which: - R1 means a hydrogen atom, a linear or branched C1-C6 alkyl radical; ...
|
WO/2016/102475A1 |
The present invention relates to the cosmetic use, in a composition containing a physiologically acceptable medium, of at least one compound of formula (I) in which: - R3 means a hydrogen atom or a hydroxyl radical, - R1 and R2 mean, ind...
|
WO/2016/096566A1 |
The present invention relates to a method of preparing chromanes from 2,5-dimethylfuran and substituted alkynes comprising an long chain unsaturated alkyl group as substituent in the alpha position of a substituted phenol followed by oxi...
|
WO/2016/095870A1 |
Provided are a bisphenol and diamine containing benzocyclobutene structural unit, and preparation and application thereof; specifically, the present invention uses 4-halo-benzocyclobutene as a raw material to obtain 4-acyl-benzocyclobute...
|
WO/2016/092076A1 |
The present invention relates to novel compounds of formula (I) to cosmetic compositions comprising same, and also to the use thereof for preventing and/or cosmetically treating the signs of aging of the skin.
|